<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100665'>Angioedema</z:hpo> caused by <z:e sem="disease" ids="C0019243" disease_type="Disease or Syndrome" abbrv="HANE|HAE">C1 inhibitor deficiency</z:e> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> that may be either hereditary or acquired, the latter being mainly associated with <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A 51-year-old woman who had suffered from episodes of <z:hpo ids='HP_0011009'>acute</z:hpo> peripheral <z:hpo ids='HP_0000969'>edema</z:hpo> since she was 12 was diagnosed with hereditary <z:hpo ids='HP_0100665'>angioedema</z:hpo> at the age of 40 and remained stable with stanozolol </plain></SENT>
<SENT sid="2" pm="."><plain>Due to a worsening of her symptoms she was reassessed and low levels of C1q and an abnormal lymphocyte count were detected </plain></SENT>
<SENT sid="3" pm="."><plain>Immunophenotyping of peripheral blood revealed 9% monoclonal lambda B cells with a follicular center phenotype </plain></SENT>
<SENT sid="4" pm="."><plain>The histopathology was consistent with a grade II follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> stage IV-A.With chemotherapy, the <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic disease</z:e> was controlled and C1q levels returned to <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="5" pm="."><plain>This represents a rare case of a patient with hereditary <z:hpo ids='HP_0100665'>angioedema</z:hpo> who developed acquired <z:hpo ids='HP_0100665'>angioedema</z:hpo> due to a <z:hpo ids='HP_0002665'>lymphoma</z:hpo> that was associated with a reduction in the levels of C1q as her symptoms worsened </plain></SENT>
</text></document>